< MON > C(3);

Motor octane number, MON

South Eastern- Mon State

MON TUE WED THU FRI SAT SUN

MON FRI TUE SAT WED SUN THU

Mon Tue Wed Thurs Fri Sat Sun

MON 1 MON 2 TUE 1 TUE 2 WED 1 WED 2 THU 1 THU 2 FRI 1 FRI 2 SAT 1 SAT 2 SUN 1 SUN 2

Chief of Bureau of Special Operations 4 (Karen, Mon, Tenasserim)

Chief of Bureau of Special Operations 4 (Karen, Mon, Tenas-serim)

Commission Decision of 31 May 1999 recognising in principle the completeness of the dossiers submitted for detailed examination in view of the possible inclusion of ZA 1296 (mesotrione), Iodosulfuron-methyl-sodium (AEF 115008) Silthiopham (MON 65500) and Gliocladium catenulatum in Annex I to Council Directive 91/414/EEC concerning the placing of plant- protection products on the market (notified under document number C(1999) 1400) (Text with EEA relevance)

MON:...

Mixed Oxides of Nitrogen (MON);

Sun/ Wed Mon/ Thu Tue/ Fri Wed/ Sat Thu/ Sun Fri/ Mon Sat/ Tue

MON, TUE, WED, THU, FRI, SAT, SUN

< MON, TUE, WED, THU, FRI, SAT, SUN, >

Calendar days Mon Tue Wed Thu Fri Sat Sun

mon/ year Use within 3 hours after dilution

Application Instructions – (Mon, Wed and Fri) 1.

Application Instructions – (Mon, Tues, Wed, Thurs and Fri) 1.

to inform European grain traders of the authorisation of maize line MON 810 and to provide them with full product information,

for blisters of 7 tablets – the abbreviated days of the week may be printed on the foil for each tablet i. e. MON, TUE, WED, THU, FRI, SAT, SUN

Whereas a dossier for the active substance Silthiopham (MON 65500) was submitted by Monsanto Crop Protection to the Irish authorities on 14 December 1998;

Mixed Oxides of Nitrogen (MON) are solutions of Nitric Oxide (NO) in Dinitrogen Tetroxide/Nitrogen Dioxide (N2O4/NO2) that can be used in missile systems.

COMMISSION DECISION of 22 April 1998 concerning the placing on the market of genetically modified maize (Zea mays L. line MON 810), pursuant to Council Directive 90/220/EEC

Whereas the dossiers for ZA 1296 (mesotrione), Iodosulfuron-methyl-sodium (AEF 115008), Silthiopham (MON 65500) and Gliocladium catenulatum were referred to the Standing Committee on Plant Health on 11 February 1999;

Opinion of the Scientific Committee on Plants regarding the evaluation of MON 37500 (sulfosulfuron) in the context of Directive 91/414/EEC concerning the placing of plant protection products on the market (SCP/SULFO/002-final dated 11 December 2000).

inbred lines and hybrids derived from maize line MON 810 containing the cryIA (b) gene from Bacillus thuringiensis subsp. kurstaki under the control of the enhanced 35S promoter from cauliflower mosaic virus and an intron from the gene coding for the heat shock protein 70 from maize.

The dossier submitted by Monsanto Crop Protection to the Commission and the Member States with a view to the inclusion of Silthiopham (MON 65500) as an active substance in Annex I to Directive 91/414/EEC and which was referred to the Standing Committee on Plant Health on 11 February 1999.

to inform international maize traders in those countries where maize line MON 810 is authorised for production, that this maize has been authorised for production, that it has been developed using genetic modification techniques and that shipments of grains may contain genetically modified grains,

COMMISSION DECISION of 31 May 1999 recognising in principle the completeness of the dossiers submitted for detailed examination in view of the possible inclusion of ZA 1296 (mesotrione), Iodosulfuron-methyl-sodium (AEF 115008) Silthiopham (MON 65500) and Gliocladium catenulatum in Annex I to Council Directive 91/414/EEC concerning the placing of plant-protection products on the market

Whereas it is understood between the Member States and the Commission that the United Kingdom will pursue the detailed examination for the dossier for ZA 1296 (mesotrione), that Germany will pursue the detailed examination for the dossier for Iodosulfuron-methyl-sodium (AEF 115008), that Ireland will pursue the detailed examination for the dossier for Silthiopham (MON 65500), and that Finland will pursue the detailed examination for the dossier for Gliocladium catenulatum;